FDA Approved: NICOTINE — Original Application (P & L Development, LLC)

View source ↗

Summary

FDA approved the original ANDA for nicotine polacrilex, a nicotine replacement therapy product, submitted by P & L Development, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• NICOTINE POLACRILEX (nicotine polacrilex)

Snippet

ORIG AP for NICOTINE (NICOTINE POLACRILEX)